Central banks in major economies are taking a more cautious, data focused stance as inflation and interest rate expectations adjust to recent energy price moves. That creates a window where fast growing companies with high insider ownership can stand out. Insiders have significant skin in the game and analysts see room for growth. This article highlights three stocks from the Fast Growing Stocks With High Insider Ownership screener that fit this theme.

The three stocks covered below are just a starting sample, and the full screen surfaced 1,301 more companies with similarly compelling growth and insider ownership stories that are not included here. To identify potential ideas that fit your own conviction level, head straight into the Fast Growing Stocks With High Insider Ownership screener to filter and analyze the full set of opportunities.

Arista Networks (ANET)

Overview: Arista Networks builds high performance networking hardware and software that connects modern data centers, AI clusters, campuses and cloud environments, using its EOS operating system and related applications to help customers manage huge volumes of data traffic efficiently.

Market Cap: US$240.3b

Arista Networks sits at the center of AI and cloud buildouts, with its AI fabric and data center platforms helping some of the largest internet and cloud customers handle growing traffic. Earnings growth has been strong over the past five years and returns on equity and margins are high, which points to an efficient and highly profitable business model. Recent quarters have shown solid revenue and EPS performance, supported by AI demand and improved supply conditions. The flip side is a rich valuation, concentrated exposure to a few very large customers, and recent insider selling that may give some investors pause. If you want a closer look at how growth expectations, margins and these risks fit together, there is more to unpack in Arista’s full story.

Arista Networks appears to be one of the clearest AI infrastructure plays, yet rich pricing, customer concentration and insider selling could be masking the real risk reward skew. See how the growth story lines up with the 2 key rewards and 1 important warning sign

Build your own high growth and insider owned shortlist

Arista Networks and the two other stocks in this article all came from a single screen, but the real advantage comes when you tailor the filters yourself. Use our flexible Screener to mix growth, valuation, quality and risk metrics to suit your style, or start with any of our curated Investing Ideas for ready made shortlists.

Universal Music Group (ENXTAM:UMG)

Overview: Universal Music Group is a global music company that signs and develops artists and songwriters, then earns revenue by recording, publishing and licensing their music across streaming platforms, physical formats, live events, film and TV, and branded merchandise.

Operations: Universal Music Group generates most of its revenue from Recorded Music at €9.8b, with additional income from Music Publishing at €2.3b and Merchandising and Other activities at €774 million.

Market Cap: €26.6b

Universal Music Group sits at the center of paid streaming, premium tiers and AI linked partnerships. Together these provide recurring revenue and opportunities to lift average revenue per user over time. At the same time, the stock has fallen sharply after subscription growth and copyright income missed expectations, even as analysts still forecast earnings growth above the wider Dutch and European markets. Investors need to weigh the draw of a huge recorded and publishing catalog, a 3.43% dividend and large buybacks against a very high P/E, a leveraged balance sheet, dependence on superstar artists and uncertainty around AI and short form monetization. The key consideration is whether recent weakness has reset expectations enough for patient holders of Universal Music Group.

Universal Music Group’s streaming engine and catalog strength are being weighed against a high P/E and leverage, which makes the full story easy to misread. Get the context in the 2 key rewards and 4 important warning signs

Harrow (HROW)

Overview: Harrow is a US based eyecare pharmaceutical company that develops and sells a wide range of prescription eye treatments, from compounded ophthalmology medications to branded and biosimilar drugs for conditions such as cataracts, ocular inflammation, infections and age related macular degeneration.

Operations: Harrow generates about $199 million from its Branded segment and $70 million from Compounding, with all reported revenue of roughly $269 million coming from the United States.

Market Cap: $1.5b

Harrow stands out in this high growth, high insider ownership screen because it couples a broad ophthalmic portfolio with forecasts for rapid revenue and earnings growth, even though it is still loss making today. Analysts see revenue growing much faster than the wider US market and expect a shift back to profitability within 3 years, while Simply Wall St’s DCF points to a current share price well below estimated fair value. Recent deals with Samsung Bioepis for BYOOVIZ and OPUVIZ and the VERKAZIA relaunch show how the product mix is evolving. The catch is heavy reliance on a handful of flagship drugs, high external borrowing and a relatively young management team, which keep execution and balance sheet risk firmly on the table.

Harrow’s accelerating revenue story and high insider ownership put its current share price in a different light. See how the growth forecasts stack up in the analyst forecasts for Harrow and where the real pressure point might be.

Seeking Alternatives Before Momentum Flies

Fresh stock ideas can move from quiet accumulation to full breakout before most investors even notice. Use these under the radar lists while it matters and look for opportunities early.

• Spot steady compounders with resilient cash flows by running the list of solid balance sheet and fundamentals (50 results) before the crowd catches on and valuations tighten.
• Look for accelerating price and earnings strength by scouting the 68 profitable AI stocks that aren't just burning cash while enthusiasm is still building and not fully reflected in prices.
• Target reliable income streams by scanning the 8 dividend fortresses while yields remain elevated and investors are focused elsewhere.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.